Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tohru Sugimoto

Showing results (41-50 of 87) with videos related to

Pageof 9
Sort By:
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|May 29, 2008
Hematopoietic contribution to skeletal muscle regeneration in acid alpha-glucosidase knockout miceJun Mori, Yasunori Ishihara, Kensuke Matsuo, et al.
Leukemia & Lymphoma|May 9, 2008
Ikaros dominant negative isoform (Ik6) induces IL-3-independent survival of murine pro-B lymphocytes by activating JAK-STAT and up-regulating Bcl-xl levelsGen Kano, Akira Morimoto, Mami Takanashi, et al.
Cancer Genetics and Cytogenetics|June 20, 2002
Newly established clear cell sarcoma (malignant melanoma of soft parts) cell line expressing melanoma-associated Melan-A antigen and overexpressing C-MYC oncogeneHiroshi Moritake, Tohru Sugimoto, Yujiro Asada, et al.
European Journal of Pharmacology|August 13, 2004
Drug-drug interactions of Z-338, a novel gastroprokinetic agent, with terfenadine, comparison with cisapride, and involvement of UGT1A9 and 1A8 in the human metabolism of Z-338Shigeru Furuta, Emiko Kamada, Takeshi Omata, et al.
Epilepsia|August 16, 2003
Ring chromosome 14 with localization-related epilepsy: three casesMasafumi Morimoto, Tomohiro Usuku, Masayuki Tanaka, et al.
Japanese Journal of Clinical Oncology|May 22, 2016
Residual tumor in cases of intermediate-risk neuroblastoma did not influence the prognosisTomoko Iehara, Shigeki Yagyu, Kunihiko Tsuchiya, et al.
Journal of Pediatric Hematology/Oncology|April 28, 2004
Early blastic transformation following complete cytogenetic response in a pediatric chronic myeloid leukemia patient treated with imatinib mesylateAkira Morimoto, Aya Ogami, Tomohiro Chiyonobu, et al.
Cancer Research|November 17, 2005
Methylation-associated silencing of the nuclear receptor 1I2 gene in advanced-type neuroblastomas, identified by bacterial artificial chromosome array-based methylated CpG island amplificationAkiko Misawa, Jun Inoue, Yuriko Sugino, et al.
Plos One|September 30, 2009
Lysosomal-associated protein multispanning transmembrane 5 gene (LAPTM5) is associated with spontaneous regression of neuroblastomasJun Inoue, Akiko Misawa, Yukichi Tanaka, et al.
Cancer Letters|December 27, 2012
A MYCN-amplified cell line derived from a long-term event-free survivor among our sixteen established neuroblastoma cell linesTohru Sugimoto, Takahiro Gotoh, Sigeki Yagyu, et al.
Pageof 9

Showing results (41-50 of 87) with videos related to

Sort By:
Pageof 9
The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society|May 29, 2008
Hematopoietic contribution to skeletal muscle regeneration in acid alpha-glucosidase knockout miceJun Mori, Yasunori Ishihara, Kensuke Matsuo, et al.
Leukemia & Lymphoma|May 9, 2008
Ikaros dominant negative isoform (Ik6) induces IL-3-independent survival of murine pro-B lymphocytes by activating JAK-STAT and up-regulating Bcl-xl levelsGen Kano, Akira Morimoto, Mami Takanashi, et al.
Cancer Genetics and Cytogenetics|June 20, 2002
Newly established clear cell sarcoma (malignant melanoma of soft parts) cell line expressing melanoma-associated Melan-A antigen and overexpressing C-MYC oncogeneHiroshi Moritake, Tohru Sugimoto, Yujiro Asada, et al.
European Journal of Pharmacology|August 13, 2004
Drug-drug interactions of Z-338, a novel gastroprokinetic agent, with terfenadine, comparison with cisapride, and involvement of UGT1A9 and 1A8 in the human metabolism of Z-338Shigeru Furuta, Emiko Kamada, Takeshi Omata, et al.
Epilepsia|August 16, 2003
Ring chromosome 14 with localization-related epilepsy: three casesMasafumi Morimoto, Tomohiro Usuku, Masayuki Tanaka, et al.
Japanese Journal of Clinical Oncology|May 22, 2016
Residual tumor in cases of intermediate-risk neuroblastoma did not influence the prognosisTomoko Iehara, Shigeki Yagyu, Kunihiko Tsuchiya, et al.
Journal of Pediatric Hematology/Oncology|April 28, 2004
Early blastic transformation following complete cytogenetic response in a pediatric chronic myeloid leukemia patient treated with imatinib mesylateAkira Morimoto, Aya Ogami, Tomohiro Chiyonobu, et al.
Cancer Research|November 17, 2005
Methylation-associated silencing of the nuclear receptor 1I2 gene in advanced-type neuroblastomas, identified by bacterial artificial chromosome array-based methylated CpG island amplificationAkiko Misawa, Jun Inoue, Yuriko Sugino, et al.
Plos One|September 30, 2009
Lysosomal-associated protein multispanning transmembrane 5 gene (LAPTM5) is associated with spontaneous regression of neuroblastomasJun Inoue, Akiko Misawa, Yukichi Tanaka, et al.
Cancer Letters|December 27, 2012
A MYCN-amplified cell line derived from a long-term event-free survivor among our sixteen established neuroblastoma cell linesTohru Sugimoto, Takahiro Gotoh, Sigeki Yagyu, et al.
Pageof 9